您現在的位置 :

醫療團隊

專業的醫護人員，提供最佳的醫療服務

醫師介紹

  •

王景弘醫師

肝癌局部治療、介入性超音波、肝炎診斷及治療
  • 國語,英語,閩南語
  • 教授
醫師網路掛號
直接點選進入醫師網路掛號畫面
醫師資歷
  • 現職
    • 高雄長庚紀念醫院胃腸肝膽科系教授級主治醫師
    • 長庚大學 醫學系 兼任教授 (2019.08)
    • 高雄市肝病防治協會 第7屆理事長 （202310-202510)
  • 學歷
    • 高雄醫學院醫學系畢
  • 經歷
    • 高雄醫學院附設醫院內科住院醫師
    • 高雄醫學院附設醫院保健科及肝膽內科主治醫師
    • 嘉義華濟醫院肝膽內科主任
    • 日本久留米大學附設醫院 病理部研修
    • 高雄長庚醫院肝臟科主任
    • 台灣肝癌醫學會第三屆監事
    • 台灣腫瘤消融醫學會 第三屆理事
    • 中華民國醫用超音波學會第十二屆監事
    • 高雄市肝病防治協會 第三屆理事長、第四屆理事長
    • 長庚大學 醫學系兼任副教授 (2013.08-2019.07)
  • 學會與認證
    • 台灣內科醫學會內科專科醫師及指導醫師
    • 台灣消化系醫學會消化系內科專科醫師及指導醫師
    • 台灣消化系內視鏡醫學會消化系內視鏡專科醫師
    • 中華民國醫用超音波學會超音波專業醫師及指導醫師
    • 台灣肝癌醫學會專科醫師
    • 台灣腫瘤消融學會認證肝腫瘤消融手術醫師
    • 台灣醫學教育學會一般醫學師資
  • 論文及期刊發表
    • Wang JH, Ou HY, Yen YH, Hung CH, Lu SN*. Usefulness of controlled attenuation parameter in monitoring clinically relevant decline of hepatic steatosis for non-alcoholic fatty liver disease. Liver Int. 2023 Sep;43(9):1901-1908. (SCI)
      可控衰減參數監測非酒精脂肪肝病患達具臨床意義的肝臟脂肪量減少的效用
    • Tien HM, Cheng TC(co-first), Lien HC, Yang KF, Shy CG, Chen YL, Hsu NT, Lu SN*, Wang JH*. Liver Disease Screening and Hepatitis C Virus Elimination in Taiwan Rural Indigenous Townships: Village-By-Village Screening and Linking to Outreach Hepatology Care. Int J Environ Res Public Health. 2022 Mar 10;19(6):3269. (SCI)
      台灣偏遠原住民鄉肝病篩檢及Ｃ型肝炎消除- 逐村篩檢及連結外展肝病專科門診的照護模式
    • Kuo YH, Kee KM, Hung CH, Lu SN, Hu TH, Chen CH, Wang JH*. Liver stiffness-based score at sustained virologic response predicts liver-related complications after eradication of hepatitis C virus. Kaohsiung J Med Sci. 2022 Mar;38(3):268-276. (SCI)
      基於肝硬度的分數可預測根除Ｃ型肝炎病毒後的肝臟相關並發症風險
    • Wang JH, Chen YY, Kee KM, Wang CC, Tsai MC, Kuo YH, Hung CH, Li WF, Lai HL, Chen YH*. The Prognostic Value of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Patients with Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab. Cancers (Basel). 2022 Jan 11;14(2):343. (SCI)
      嗜中性球/淋巴球比值和血小板/淋巴球比值在肝癌病人接受ATEZOLIZUMAB和BEVACIZUMAB的預後意義
    • Kuo YH, Lu SN, Chen YY, Kee KM, Yen YH, Hung CH, Hu TH, Chen CH, Wang JH*. Real world Lenvatinib versus Sorafenib in patients with advanced hepatocellular carcinoma: A Propensity Score Matching analysis. Front Oncol. 2021 Oct 25;11:737767. (SCI)
      現實世界晚期肝癌病人使用樂衛瑪(LENVATINIB)和蕾莎瓦(SORAFENIB)的比較- 一個傾向分數配對分析
    • Kuo YH, Yen YH, Chen YY, Kee KM, Hung CH, Lu SN, Hu TH, Chen CH, Wang JH*. Nivolumab Versus Regorafenib in Patients With Hepatocellular Carcinoma After Sorafenib Failure. Front Oncol. 2021 May 31;11:683341. (SCI)
      肝癌病人蕾莎瓦治療失敗後, 使用保疾伏和癌瑞格的比較
    • Wang JH#, Li WF#, Yong CC, Liu YW, Lu SN, Wang CC*. Liver stiffness and insulin resistance in predicting recurrence for early stage hepatoma patients after curative resection. Sci Rep. 2021 Mar 15;11(1):6041. (SCI)
      肝硬度及胰島素抗性對早期肝癌病人治癒切除手術後復發的預測作用
    • Lin ZY*, Wang JH*, Yeh ML, Huang CI, Kee KM, Yen YH, Chen SC, Huang CF, Huang JF, Dai CY, Yu ML, Chuang WL. Primary cultures of aspiration residual specimens predict outcomes of hepatocellular carcinoma patients receiving curative treatment. Kaohsiung J Med Sci. 2020 Sep;36(9):750-756. (SCI)
      肝結節抽吸剩餘檢体的細胞培養預測肝癌病患治癒性治療後的預後
    • Yeh WS, Chiang PL, Kee KM, Chang CD, Lu SN, Chen CH, Wang JH*. Pre-sarcopenia Is the Prognostic Factor of Overall Survival in Early-Stage Hepatoma Patients Undergoing Radiofrequency Ablation. Medicine (Baltimore). 2020 Jun 5;99(23):e20455. (SCI)
      肌少症前期是早期肝癌患者接受射頻燒灼術的死亡預測因子
    • Wang JH, Ou HY, Yen YH, Chen CH, Lu SN*. Usefulness of Controlled Attenuation Parameter in Detecting and Monitoring Hepatic Steatosis with MRI-PDFF as Reference. Dig Dis Sci. 2020 May;65(5):1512-1519. (SCI)
      以核磁共振檢查質子密度脂肪分數為標準，評估肝臟脂肪變受控衰減參數偵測及追蹤肝臟脂肪變化的用處
    • Wang JH, Chen CH, Chang CM, Feng WC, Lee CY, Lu SN*. Hepatitis C virus core antigen is cost-effective in community-based screening of active hepatitis C infection in Taiwan. J Formos Med Assoc. 2020 Jan;119(1 Pt 3):504-508. (SCI)
      C型肝炎核心抗原是社區篩檢活動性C型肝炎經濟有效的工具
    • Wang JH. Shear wave elastography for biliary hamartoma: An ancillary to diagnosis? Adv Dig Med. 2019 Dec;6(4): 144-145. (台灣消化醫學雜誌) Editorial
      剪波超音波彈性度檢查於膽道缺陷腫瘤的診斷輔助性工具?
    • Wang JH, Hu TH, Chen CH, Hung CH, Yen YH, Chang KC, Lu SN*. Liver stiffness measurement at complete virological response in hepatoma prediction for HBV-related cirrhosis patient with potent antiviral agent. Kaohsiung J Med Sci. 2019 Nov;35(11):708-714. (SCI)
      B型肝炎相關肝硬化病人抗病毒治癒達完全病毒反應時肝硬度測量對肝癌發生的預測
    • Lee YC, Hu TH, Hung CH, Lu SN, Chen CH, Wang JH*. The change in liver stiffness, controlled attenuation parameter and fibrosis-4 index for chronic hepatitis C patients with direct-acting antivirals. PLoS One. 2019 Apr 2;14(4):e0214323. (SCI)
      慢性C型肝炎基因型第一型病人DAA藥物治療肝硬化度變化及其關影響因子
    • Wang JH, Yen YH, Yao CC, Hung CH, Chen CH, Hu TH, Lee CM, Lu SN*. Liver stiffness-based score in hepatoma risk assessment for chronic hepatitis C patients after successful antiviral therapy. Liver Int. 2016 Dec;36(12):1793-1799.(SCI)
      以肝纖維化測量為基礎的分數預測慢性C型肝炎病人治療成功後的肝癌發生風險
    • Wang JH(co-first), Chen TY(co-first), Ou HY, Wang CC, Liu YW, Hung CH, Chen CH, Kuo CH, Hu TH, Cheng YF, Lu SN*. Clinical Impact of Gadoxetic Acid-Enhanced Magnetic Resonance Imaging on Hepatoma Management: A Prospective Study. Dig Dis Sci. 2016 Apr;61(4):1197-205. (SCI)
      Primovist 核磁共振檢查影響肝癌臨床處理的前瞻研究
    • Wang JH, Kee KM, Lin CY, Hung CH, Chen CH, Lee CM, Lu SN*. Validation and modification of a proposed substaging system for patients with intermediate hepatocellular carcinoma. J Gastroenterol Hepatol. 2015 Feb;30(2):358-63. (SCI)
      驗證及修改一個中期肝癌病患次分期系統
    • Kuo YH, Chung KC, Hung CH, Lu SN, Wang JH*. The impact of general anesthesia on radiofrequency ablation of hepatocellular carcinoma. Kaohsiung J Med Sci. 2014 Nov;30(11):559-65. (SCI)
      全身麻醉對於肝癌射頻燒灼術的影響
    • Wang JH*, Chuah SK(co-first), Lu SN, Hung CH, Kuo CM, Tai WC, Chiou SS. Baseline and serial liver stiffness measurement in prediction of portal hypertension progression for patients with compensated cirrhosis. Liver Int. 2014 Oct;34(9):1340-8. (SCI)
      初次及連續的肝彈性度檢查對代償肝硬化病人門脈高壓進展的預測
    • Kuo YH, Lu SN, Chen CH, Chang KC, Hung CH, Tai WC, Tsai MC, Tseng PL, Hu TH, Wang JH*. The changes of liver stiffness and its associated factors for chronic hepatitis B patients with entecavir therapy. PLoS One. 2014 Mar 28;9(3):e93160. (SCI)
      慢性B型肝炎病人接受貝樂克治療後肝臟硬度值的變化和其相關因子
    • Wang JH*, Hung CH, Kuo FY, Eng HL, Chen CH, Lee CM, Lu SN, Hu TH. Ultrasonographic Quantification of Hepatic-Renal Echogenicity Difference in Hepatic Steatosis Diagnosis. Dig Dis Sci. 2013 Oct;58(10):2993-3000. (SCI)
      超音波定量肝腎音波強度差異來診斷肝脂肪的效用
    • Wang JH, Lu SN*. Response to Giannini et al. Am J Gastroenterol. 2013 Jul;108(7):1175. (SCI)
      回應：肝癌篩檢適當間隔
    • Wang JH*#, Kuo YH#, Wang CC, Chen CL, Cheng YF, Hsu HC, Lu SN. Surgical resection improves the survival of selected hepatocellular carcinoma patients in Barcelona clinic liver cancer stage C. Dig Liver Dis. 2013 Jun;45(6):510-515. (SCI) (#: co-first author)
      外科切除肝癌改善經選擇的BCLC晚期肝癌病人的存活
    • Hsieh YC, Yap YS, Hung CH, Chen CH, Lu SN, Wang JH*. Factors related to postoperative pain among patients who underwent radiofrequency ablation of hepatocellular carcinoma.Clin Radiol. 2013 Jun;68(6):600-7. (SCI)
      影響肝癌病人射頻燒灼術後疼痛因素分析
    • Wang HM, Hung CH, Lu SN, Chen CH, Lee CM, Hu TH, Wang JH*. Liver stiffness measurement as an alternative to fibrotic stage in risk assessment of hepatocellular carcinoma incidence for chronic hepatitis C patients. Liver Int. 2013 May;33(5):756-61. (SCI)
      肝硬度測量替代肝組織纖維化程度對慢性C型肝炎病人肝癌發生的危險性評估
    • Wang JH, Chang KC, Kee KM, Chen PF, Yen YH, Tseng PL, Kuo YH, Tsai MC, Hung CH, Chen CH, Tai WC, Tsai LS, Chen SC, Lin SC, Lu SN*. Hepatocellular Carcinoma Surveillance at 4- vs. 12-Month Intervals for Patients With Chronic Viral Hepatitis: A Randomized Study in Community. Am J Gastroenterol. 2013 Mar;108(3):416-24. (SCI)
      肝癌4個月與12個月篩檢間隔的比較--社區的隨機比較研究
    • Xu HW, Lu SN, Hung CH, Chang KC, Hu TH, Wang JH*. Liver stiffness measurement in cirrhotic patient -- implications of disease activity and treatment efficacy. Kaohsiung J Med Sci. 2012 Dec;28(12):641-8. (SCI)
      肝硬化病人的肝硬化度測量-疾病活動性及治療的影響
    • Wang JH*, Chuah SK, Lu SN, Hung CH, Chen CH, Kee KM, Chang KC, Tai WC, Hu TH. Transient elastography and simple blood markers in the diagnosis of esophageal varices for compensated patients with hepatitis B virus-related cirrhosis. J Gastroenterol Hepatol. 2012 Jul;27(7):1213-8. (SCI)
      肝硬化度檢查及簡單血液檢驗對B型肝炎病毒相關的代償肝硬化病人食道靜脈屈張診斷的評估
    • Wang JH, Wang CC, Hung CH, Chen CL, Lu SN*. Survival comparison between surgical resection and radiofrequency ablation for patients in BCLC very early/early stage hepatocellular carcinoma. J Hepatol. 2012 Feb; 56(2): 412–418. (SCI)
      極早期及早期肝癌病人接受開刀切除或射頻燒灼術治療的存活比較
    • Chang KC, Lu SN, Chen PF, Hung CH, Kee KM, Yen YH, Wang JH*. Incidence and associated risk factors of hepatocellular carcinoma in a dural hepatitis B and C virus endemic area: a surveillance study. Kaohsiung J Med Sci. 2011 Mar;27(3):85-90. (SCI)

    • Wang JH, Tung HD, Chen TY, Hung CH, Chen CH, Changchien CS, Hu TH, Lee CM, Lu SN*. Radiofrequency ablation of small hepatocellular carcinoma with intravenous pegylated liposomal doxorubicin. Hepatol Int. 2011 Mar; 5(1): 567-574. (SCI)
      射頻燒灼術合併靜脈注射PLD對小型肝癌的效果評估
    • Kuo YH, Lu SN, Hung CH, Kee KM, Chen CH, Hu TH, Lee CM, Changchien CS, Wang JH*. Liver stiffness measurement in the risk assessment of hepatocellular carcinoma for patients with chronic hepatitis. Hepatol Int. 2010 Oct 8;4(4):700-6. (SCI)
      肝癌篩檢即是當治療改善肝硬化病人存活率
    • Chen JY, Chiang JC, Lu SN, Hung SF, Kao JT, Yen YH, Wang JH*. Changing prevalence of anti-hepatitis A virus in adolescents in a rural township in Taiwan. Chang Gung Med J. 2010 May-Jun;33(3):321-6.

    • Chang CJ, Chiang JC, Lu SN, Wang JH*. Hepatitis delta virus and GBV-C infection in two neighboring hepatitis B virus and hepatitis C virus-endemic villages in Taiwan. Chang Gung Med J. 2010 Mar-Apr;33(2):137-44.

    • Wang JH, Changchien CS, Hung CH, Tung WC, Kee KM, Chen CH, Hu TH, Lee CM, Lu SN*. Liver stiffness decrease after effective antiviral therapy in patients with chronic hepatitis C: Longitudinal study using FibroScan. J Gastroenterol Hepatol. 2010 May;25(5):964-9. (SCI)
      慢性C肝炎病人經有效抗病毒治療肝硬化度減低-以肝纖維測定儀定量的長期研究
    • Kuo YH, Lu SN, Chen CL, Cheng YF, Lin CY, Hung CH, Chen CH, Changchien CS, Hsu HC, Hu TH, Lee CM, Wang JH*. Hepatocellular carcinoma surveillance and appropriate treatment options improve survival for patients with liver cirrhosis. Eur J Cancer. 2010 Mar;46(4):744-51. (SCI)

    • Wang JH, Changchien CS, Hung CH, Eng HL, Tung WC, Kee KM, Chen CH, Hu TH, Lee CM, Lu SN*. FibroScan and ultrasonography in the prediction of hepatic fibrosis in patients with chronic viral hepatitis. J Gastroenterol. 2009 Mar;44(5):439-46. (SCI)
      肝纖維化測定化及超音波對慢性病毒性肝炎病人評估肝纖維化程度的效用
    • Wang JH, Changchien CS, Hu TH, Lee CM, Kee KM, Lin CY, Chen CL, Chen TY, Huang YJ, Lu SN*. The efficacy of treatment schedules according to Barcelona Clinic Liver Cancer staging for hepatocellular carcinoma - Survival analysis of 3892 patients. Eur J Cancer 2008 May;44(7):1000-6. (SCI)
      以巴塞隆納肝癌分期為治療指引的不同療法治療成效比較--3892 肝癌病人的存活分析
    • Kuo YH, Wang JH*, Hu TH, Lee CM. Primary Hepatocellular Carcinoma in Ectopic Liver and Later Metastasis to Mother Liver: A Case Report and Review of the Literature. J Intern Med Taiwan 2008 Oct; 19(1):422-7.

    • Wang JH, Changchien CS*. Contrast-enhanced Ultrasonography in Small Liver Tumors (< 3 cm). Journal of Medical Ultrasound. 2008 March;16(1): 26-40. (Review Articles)

    • Yen YH, Wang JH*, Lu SN, Chen TY, Changchien CS, Chen CH, Hung CH, Lee CM. Contrast-enhanced ultrasonographic spoke-wheel sign in hepatic focal nodular hyperplasia. Eur J Radiol 2006 Dec;60(3):439-44. (SCI)

    • Wang JH*, Lu SN, Tung HD, Changchien CS, Hung CH, Chen CH, Lee CM. Flash-echo contrast sonography in the evaluation of response of small hepatocellular carcinoma to percutaneous ablation. J Clin Ultrasound. 2006 Apr 13;34(4):161-168. (SCI)
      閃爍造影劑超因波對小型肝癌經皮局部去除治療後的效果評估
    • Wang JH*, Lu SN, Hung CH, Chen TY, Chen CH, Changchien CS, Lee CM. Small hepatic nodules (<=2cm) in cirrhosis patients: characterization with contrast-enhanced ultrasonography. Liver Int. 2006 Oct;26(8):928-34. (SCI)
      肝硬化病人小型肝結節-以對比超音波鑑別診斷
    • Yen YH, Wang JH*, Lu SN, Changchien CS. Contrast-enhanced ultrasonography in hepatic angiomyolipoma. J Ultrasound Med. 2005 Jun;24(6):855-9. (SCI)

    • Kee KM, Wang JH*, Lee CM, Changchien CS, Eng HL. Chronic Hepatitis C Virus Infection Associated with Dermatomyositis and Hepatocellular Carcinoma. Chang Gung Med J. 2004 Nov;27(11):834-9. Review.

    • Chou YP, Lee PL, Cheng YF, Lu SN, Changchien CS, Wang JH*. Fatal arterioportal shunting in a case of hepato-cellular carcinoma with spontaneous partial recression of malignant portal vein thrombosis. Gastroenterological Journal of Taiwan 2003 December; 20(4): 245-251.

    • Wang JH, Lu SN*, Changchien CS, Huang WS, Hung CH, Tung HD, Chen TM, Lee CM. Flash echo gray-scale imaging with subtraction for assessing perfusion of small hepatocellular carcinoma. J Clin Ultrasound 2003 Nov;31(9):451-6. (SCI)
      閃爍灰階超音波對小型肝癌灌流研究
    • Chen TM, Lu SN, Wang JH*, Hung CH, Tung HD. Relationship between flash echo gray scale imaging features and pathologic findings in hepatic adenoma. J Ultrasound Med. 2002 Jul;21(7):821-4. (SCI)

    • Wang JH, Chen TM, Tung HD, Lee CM, Changchien CS, Lu SN*. Color Doppler sonography of bile duct tumor thrombi in hepatocellular carcinoma. J Ultrasound Med. 2002 Jul;21(7):767-72. (SCI)
      肝癌膽道拴塞之彩色超音波圖像
    • Wang JH, Lu SN, Lee CM*, Lee JF, Chou YP. Fatal hepatic failure after emergence of the hepatitis B virus mutant during lamivudine therapy in a patient with liver cirrhosis. Scand J Gastroenterol. 2002 Mar; 37(3):366-9. Case Reports. (SCI)
      一位肝硬化病人使用拉美芙錠發生B型肝炎突變急症導致肝衰竭死亡
    • Wang JH, Lu SN*, Changchien CS, Lee CM, Tung HD, Chen TM. Flash echo gray scale imaging with subtraction in assessment of small hepatocellular carcinoma treated with percutaneous ethanol injection: preliminary report. J Ultrasound Med. 2001 May; 20(5):539-44. (SCI)
      閃爍超音波對小型肝癌以酒精注射後療效評估
    • Wang JH, Lu SN, Wu JC, Huang JF, Yu ML, Chen SC, Chuang WL. A hyperendemic community of hepatitis B virus and hepatitis C virus infection in Taiwan. Trans R Soc Trop Med Hyg. 1999 May-Jun; 93(3):253-4. (SCI)

    • Wang JH, Lu SN, Hsu CT. Hepatitis C is one major viral etiology of hepatocellular carcinoma in Chiayi and Yingling. J Int Med Taiwan 1998 Sep; 9(3): 120-125.
      C型肝炎在雲嘉地區肝癌的重要性
    • Wang JH, Wang LY, Lin ZY, Chen SC, Kanf SC, Chuang WL, Lu SN, Hsieh MY, Tsai JF, Chang WY. Doppler sonography of common hepatic duct tumor invasion in hepatocelluylar carcinoma:report of two cases. J Ultrasound Med. 1995 Jun; 14(6):471-4. Case Reports (SCI)